GMP · FSSAI · ISO-certified manufacturing
Ingredients

Shatavari for breast milk, what can honestly be said, and what actually works

Milk supply is governed by how often and how completely the breast is emptied. No galactagogue changes that, and the evidence for shatavari is thin and mixed.

EnglishIngredients
NutraHerbal Editorial12 min read

Reviewed for accuracy and claims compliance: Claims and compliance review

This is the most commercially important claim in the shatavari market and the one we are least willing to make.

Shatavari’s classical designation as stanyajanana, milk-promoting, is genuine. It is in the texts. Its use for this purpose in India goes back a very long way.

And the modern evidence is thin, mixed, and from small studies.

But the reason we will not make the claim is not mainly about evidence quality. It is this:

Milk supply is governed by how often and how completely milk is removed from the breast. That is the mechanism. A supplement does not change it.

And a mother who is given a bottle of syrup instead of help with latch and feeding frequency has been sold something that occupies the place where the actual solution should be, during a window that closes.

We sell shatavari. This article is about why we do not sell it for this.

General information, not medical advice. If your baby is not gaining weight, or wet nappies are reduced, that is a reason to see a doctor or a lactation consultant today, not a reason to buy a supplement.

How milk supply actually works

This is the part that makes everything else follow, so it is worth setting out properly.

Lactation runs on two systems.

Endocrine control, early. In the first days after birth, the fall in progesterone after the placenta is delivered triggers milk production. This is hormonal and largely automatic.

And then autocrine control, which takes over and governs the rest. This is local, physical, and the key to everything:

Milk removal drives milk production.

Specifically: when the breast is full, a protein in the milk itself, the feedback inhibitor of lactation, accumulates and signals the breast to slow production. Empty the breast and the inhibitor is removed and production rises.

So supply is demand-led, by a local mechanism inside the breast.

Which produces the governing fact:

Frequent, effective milk removal increases supply. Infrequent or incomplete removal decreases it.

And prolactin, the hormone that gets measured in galactagogue studies, is necessary for milk production but is not the limiting factor in most mothers. A mother can have adequate prolactin and a falling supply, because the breast is not being emptied often enough.

This is why the galactagogue question is smaller than it looks. Raising prolactin in a mother whose prolactin was not the problem does not fix the problem.

The evidence on shatavari

Being fair to the ingredient, because it has more supporting work than most.

There are small Indian trials, and some report increases in prolactin levels in mothers given shatavari, and some report improvements in infant weight gain.

And there are studies that found no clear difference.

The common problems across this literature: small participant numbers; short duration; variable preparations and doses; outcome measures that differ between studies; limited blinding; and several studies conducted by or with manufacturers.

And the broader picture: systematic reviews of galactagogues in general, herbal and pharmaceutical, have repeatedly concluded that the evidence is insufficient to recommend them. That conclusion covers fenugreek, shatavari, domperidone and the rest.

So the honest statement:

There is a plausible traditional basis, a small and mixed modern literature, and no good evidence that shatavari meaningfully increases milk supply in a mother whose feeding management is already optimised.

And a point about prolactin specifically: a study showing raised prolactin is a surrogate outcome. The outcome mothers care about is milk volume and infant weight gain, and that is measured much less often.

Why “low supply” is usually something else

This is the most useful section, and it is the reason we think the supplement is the wrong answer in most cases.

Genuine primary low milk supply, where the breast cannot make enough despite everything being done correctly, exists but is uncommon. It occurs in conditions like insufficient glandular tissue, retained placenta, significant postpartum haemorrhage, previous breast surgery, PCOS in some women, and thyroid disease.

Far more often, “low supply” turns out to be one of these:

Ineffective latch. The single commonest cause. A baby who is latched shallowly transfers milk poorly, so the breast does not empty, so production falls, and the baby feeds longer and more often while gaining less, which looks exactly like low supply. Correcting a latch can change supply within days.

Infrequent feeding. Scheduled feeds, long night gaps, or “letting the breast fill up”, which is intuitive and backwards. The fuller the breast, the more the inhibitor accumulates and the slower production becomes.

Formula top-ups. Every top-up replaces a feed, so the breast is emptied less, so supply falls, so more top-ups are needed. This is the commonest way a supply genuinely declines, and it is a loop.

Pacifier use displacing feeds in the early weeks.

Nipple pain and damage, which causes a mother to shorten or avoid feeds. Usually itself caused by latch.

Perceived low supply, where supply is fine. And this is enormous. A baby who feeds frequently, or is unsettled in the evening, or no longer feels the breast as full as it did at six weeks, is almost always normal. Breasts stop feeling engorged as supply regulates, that is a sign the system is working, not failing.

Maternal exhaustion and inadequate food and fluid. Real, and more about rest and eating than about a herb.

Certain medications, including some contraceptives containing oestrogen, and pseudoephedrine.

And tongue-tie in some babies, affecting transfer.

So the diagnostic question is not “which galactagogue” but “is milk being removed often and effectively, and is supply actually low?”

And the measure of actual supply is not how the breast feels or how much a pump yields. It is the baby: weight gain, wet nappies, stools, and behaviour.

What actually increases supply

In order of effect, and none of it is a product:

1. Fix the latch. A lactation consultant or trained nurse watching a feed is the highest-value intervention available, and it is usually one session.

2. Feed more often. Eight to twelve times in twenty-four hours in the early weeks, including at night. Night feeds matter, because prolactin levels are higher at night.

3. Feed on demand, not on a schedule.

4. Empty the breast properly. Finish one side before offering the other; use breast compression; and if needed, express after feeds.

5. Reduce or eliminate unnecessary top-ups, with supervision if the baby’s weight requires care.

6. Skin-to-skin contact.

7. Treat nipple pain so feeds are not cut short.

8. Rest, eat and drink. Lactation is metabolically expensive, roughly 500 extra kilocalories a day, and a mother who is not eating enough is a real and common problem in Indian postpartum practice, where food restrictions are sometimes imposed.

9. Check thyroid and haemoglobin. Both affect lactation and both are treatable, and postpartum anaemia is very common in India.

10. And then, if a doctor advises it, a galactagogue, herbal or prescription.

Tenth. That is where it belongs.

Safety, because this is a breastfeeding mother

And the standard of caution has to be higher here, since whatever the mother takes reaches the infant.

What we can say: shatavari has a long traditional record of use in the postpartum period in India. That is meaningful observational history and it is not the same as safety data.

What we cannot say: there is no adequate modern safety data on concentrated shatavari supplements in breastfeeding, and no data on effects on the infant.

And the specific concerns:

Reported oestrogen-like activity in laboratory and animal work. And oestrogen can reduce milk supply, which is an uncomfortable theoretical possibility for a product sold to increase it. This has not been demonstrated clinically for shatavari, and it is the kind of uncertainty that should be stated rather than ignored.

Diuretic effect, reported, and a mother who needs fluids does not need a diuretic.

Allergy, anyone allergic to asparagus.

Adulteration, and this matters more in a breastfeeding mother than anywhere. Shatavari is commonly adulterated, including with safed musli, and powdered root cannot be identified by eye. Batch heavy-metal testing is not optional for a product a lactating mother takes daily, it is a root, and roots take up lead and cadmium.

And the formulation question: many “lactation” products are mixtures containing fenugreek, fennel, ajwain, ashwagandha and others. Each adds its own uncertainty, and ashwagandha in particular is a herb we would not include in a breastfeeding product. A multi-herb postpartum blend is several unknowns at once.

What we will and will not say

Sayable: the botanical name (Asparagus racemosus) and part used; a traditional-use statement framed as traditional use, including the classical stanyajanana designation described as a classical designation; the quantity; and authorised claims for any vitamins or minerals present, which for a postpartum product is actually where the real substance is: iron, B12, folate, calcium, vitamin D and iodine all have authorised nutrient-function claims and all matter after childbirth.

And the governing fact: there is no authorised health claim for shatavari.

Not sayable: increases breast milk, improves lactation, treats low milk supply, “lactation support” where that implies an effect on supply.

And three refusals, which cost us the most commercially valuable claim in this category:

We will not claim a milk-supply effect. The evidence does not support it and the mechanism is elsewhere.

We will not market a lactation product without a line directing mothers to a lactation consultant or doctor if the baby is not gaining weight. Because the harm here is delay, and the window matters.

And we will not combine shatavari with ashwagandha or other herbs lacking breastfeeding safety data and sell it as a postpartum product.

And our honest commercial position: a postpartum nutrition product that supplies iron, B12, folate, calcium, vitamin D and adequate calories is a genuinely useful thing to sell a new mother in India, where postpartum anaemia and undernutrition are common. That product can make real, authorised claims. A galactagogue claim cannot, and does not need to be there.

And the most honest summary:

Milk supply is controlled locally, by how often and how completely the breast is emptied, through a feedback inhibitor in the milk itself.

Prolactin is necessary and is rarely the limiting factor.

Most “low supply” is latch, feeding frequency, top-ups, or a perfectly normal supply being misread.

Shatavari’s classical designation is real, its modern evidence is small and mixed, and systematic reviews of galactagogues as a class find the evidence insufficient.

And one session with someone who watches a feed does more than any bottle we could sell.

When to see a doctor

Today, not later:

  • the baby is not gaining weight, or is losing weight
  • fewer than six wet nappies a day after the first week
  • very dark urine, or no stool for an unusually long period in a newborn
  • the baby is sleepy and difficult to wake for feeds, or feeds very weakly
  • a dry mouth, sunken eyes, or a sunken fontanelle, signs of dehydration; this is urgent
  • jaundice that is deepening or appears after the first week

Soon:

  • nipple pain, cracking or bleeding, this is almost always latch, and it is fixable
  • a hard, red, painful area in the breast with fever, mastitis; this needs treatment, not a supplement
  • a lump that does not resolve after a feed
  • a feeling that supply has dropped suddenly
  • the baby feeding for very long periods and still unsettled

And get checked for: thyroid function and haemoglobin, both affect lactation and both are common and treatable postpartum; and postpartum depression and anxiety, which are common, under-recognised, and treatable. If you are feeling hopeless, unable to cope, or having thoughts of harming yourself or the baby, this needs help now, Tele-MANAS is reachable on 14416.

Before taking shatavari while breastfeeding, ask about: asparagus allergy; a history of hormone-sensitive cancer; diuretic medication or lithium; kidney disease; diabetes medication; and any multi-herb blend, ingredient by ingredient.

The short version

  1. Shatavari’s classical stanyajanana designation is genuine and old
  2. The modern evidence is small, mixed and often manufacturer-involved
  3. But the deeper reason is mechanism, not evidence quality
  4. Early lactation is endocrine-driven, triggered by the progesterone fall after delivery
  5. After that, autocrine control takes over, local and physical
  6. A feedback inhibitor in the milk accumulates when the breast is full and slows production
  7. Empty the breast and production rises
  8. So supply is demand-led, by a mechanism inside the breast
  9. Prolactin is necessary but is rarely the limiting factor
  10. So raising prolactin in a mother whose prolactin was fine fixes nothing
  11. Studies reporting raised prolactin are reporting a surrogate outcome
  12. Systematic reviews of galactagogues as a class find the evidence insufficient
  13. Genuine primary low supply exists but is uncommon
  14. Ineffective latch is the commonest cause of apparent low supply
  15. A shallow latch transfers milk poorly, so the breast does not empty
  16. Correcting a latch can change supply within days
  17. “Letting the breast fill up” is intuitive and backwards
  18. Formula top-ups create a loop: less emptying, less supply, more top-ups
  19. Perceived low supply with normal supply is extremely common
  20. Breasts stop feeling engorged as supply regulates, that is the system working
  21. Actual supply is measured by the baby: weight, nappies, stools, behaviour
  22. Not by how the breast feels or how much a pump yields
  23. Night feeds matter, prolactin is higher at night
  24. Lactation costs roughly 500 extra kilocalories a day
  25. Postpartum food restriction is a real problem in Indian practice
  26. Check thyroid and haemoglobin, postpartum anaemia is very common in India
  27. A galactagogue belongs tenth on the list, on medical advice
  28. Traditional postpartum use is observational history, not safety data
  29. Reported oestrogen-like activity is awkward here, since oestrogen can reduce supply
  30. A reported diuretic effect is unhelpful in a mother who needs fluids
  31. Adulteration matters most in a lactating mother, demand batch heavy-metal testing
  32. Multi-herb postpartum blends stack several unknowns, and we would exclude ashwagandha
  33. A postpartum product’s real substance is iron, B12, folate, calcium, vitamin D and iodine
  34. Those have authorised claims; a milk-supply claim does not
  35. One session with someone who watches a feed outperforms any supplement

Ingredient detail: shatavari. Our formulations: Shatavari Juice, Women’s Nutrition Powder. Related reading: शतावरी के फ़ायदे महिलाओं के लिए, what the classical texts actually say, दूध बढ़ाने के घरेलू उपाय, postpartum recovery, the first three months, and which herbs to avoid in pregnancy.

Get our product list and minimum orders

Leave your email and we will send the formats we make, the minimum order for each and typical lead times. We use it only to reply to you.

Manufacturing in this category?

We make products in this category for other people's brands. Tell us the format and volume and we will send a specification and a per-unit cost.

Request a quotation ↗

NutraHerbal manufactures food supplements, Ayurvedic proprietary medicines and cosmetics for business customers. Product information on this site describes composition, format and commercial positioning for brand owners. It is not medical advice, does not claim to diagnose, treat, cure or prevent any disease, and is not a substitute for consulting a qualified practitioner. Final label claims are the brand owner's responsibility and must be approved for the destination market.

How we write and review content: editorial policy.

Keep reading

Related articles

All articles
Reviewed by

Tarun Vashisht

Head of Ayurvedic Formulations & Regulatory Quality

Ayurvedic physician and pharmacognosy specialist with over 15 years of experience overseeing GMP-certified herbal extractions, classical proprietary formulations, and AYUSH/FSSAI regulatory compliance for direct-selling and retail nutraceutical brands.

Your idea, made tangible

Tell us what you want to launch

Send us the format, the wellness goal and roughly the volume you have in mind. We will come back with a specification sheet, a per-unit cost and a realistic first-batch date, not a brochure.

WA